I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

By Brian Brown, president and partner at food marketing agency Ingredient  For those living on the West Coast of North ...